T-Y Yu1,2, J-H S Pang2, K P-H Wu1, L-P Lin2, W-C Tseng1, W-C Tsai1,3. 1. Department of Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital, Linkou, 333, Taiwan. 2. Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, 333, Taiwan. 3. College of Medicine, Chang Gung University, Taoyuan, 333, Taiwan.
Abstract
OBJECTIVES: To investigate effects of platelet-rich plasma on tendon cell proliferation and the underlying molecular mechanisms. MATERIALS AND METHODS: Platelet-rich plasma was prepared manually by two-step centrifugation. Proliferation was evaluated in cultured rat tendon cells by the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay. Cell cycle progression was assessed by flow cytometry. Messenger RNA expression of proliferating cell nuclear antigen (PCNA), cyclin E1, A2 and B1, and cyclin-dependent kinases (Cdks) 1 and 2 was assessed by real-time polymerase chain reaction. Protein expression of the above cyclins and Cdks and of signal transducer and activator of transcription (Stat) 3 and p27 was evaluated by western blotting. RESULTS: Platelet-rich plasma used in the present study had concentrations of platelets, TGF-β1 and PDGF over 3-fold higher than normal whole blood. Platelet-rich plasma enhanced tendon cell proliferation (P = 0.008) by promoting G1 /S phase transition in the cell cycle, and increased expression of PCNA, cyclin E1, A2 and B1, Cdks1 and 2, and phosphorylated Stat3, while inhibiting p27 expression. CONCLUSIONS: Platelet-rich plasma contains high concentrations of TGF-β1 and PDGF that increase tendon cell proliferation by modulating Stat3/p27(Kip1), which enhances expression of cyclin-Cdk complexes that promote cell cycle progression. These results provide molecular evidence for positive effects of platelet-rich plasma on tendon cell proliferation, which can be useful in clinical applications of tendon injury.
OBJECTIVES: To investigate effects of platelet-rich plasma on tendon cell proliferation and the underlying molecular mechanisms. MATERIALS AND METHODS: Platelet-rich plasma was prepared manually by two-step centrifugation. Proliferation was evaluated in cultured rat tendon cells by the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay. Cell cycle progression was assessed by flow cytometry. Messenger RNA expression of proliferating cell nuclear antigen (PCNA), cyclin E1, A2 and B1, and cyclin-dependent kinases (Cdks) 1 and 2 was assessed by real-time polymerase chain reaction. Protein expression of the above cyclins and Cdks and of signal transducer and activator of transcription (Stat) 3 and p27 was evaluated by western blotting. RESULTS: Platelet-rich plasma used in the present study had concentrations of platelets, TGF-β1 and PDGF over 3-fold higher than normal whole blood. Platelet-rich plasma enhanced tendon cell proliferation (P = 0.008) by promoting G1 /S phase transition in the cell cycle, and increased expression of PCNA, cyclinE1, A2 and B1, Cdks1 and 2, and phosphorylated Stat3, while inhibiting p27 expression. CONCLUSIONS: Platelet-rich plasma contains high concentrations of TGF-β1 and PDGF that increase tendon cell proliferation by modulating Stat3/p27(Kip1), which enhances expression of cyclin-Cdk complexes that promote cell cycle progression. These results provide molecular evidence for positive effects of platelet-rich plasma on tendon cell proliferation, which can be useful in clinical applications of tendon injury.
Authors: Fabio Celotti; A Colciago; P Negri-Cesi; A Pravettoni; R Zaninetti; M C Sacchi Journal: Wound Repair Regen Date: 2006 Mar-Apr Impact factor: 3.617
Authors: K Akeda; H S An; M Okuma; M Attawia; K Miyamoto; E J-M A Thonar; M E Lenz; R L Sah; K Masuda Journal: Osteoarthritis Cartilage Date: 2006-07-03 Impact factor: 6.576
Authors: Kristina Kapinas; Rodrigo Grandy; Prachi Ghule; Ricardo Medina; Klaus Becker; Arthur Pardee; Sayyed K Zaidi; Jane Lian; Janet Stein; Andre van Wijnen; Gary Stein Journal: J Cell Physiol Date: 2013-01 Impact factor: 6.384
Authors: Robert J de Vos; Adam Weir; Hans T M van Schie; Sita M A Bierma-Zeinstra; Jan A N Verhaar; Harrie Weinans; Johannes L Tol Journal: JAMA Date: 2010-01-13 Impact factor: 56.272
Authors: Dean Wang; Hongbo Tan; Amir H Lebaschi; Yusuke Nakagawa; Susumu Wada; Patrick E Donnelly; Liang Ying; Xiang-Hua Deng; Scott A Rodeo Journal: Arthroscopy Date: 2018-07-20 Impact factor: 4.772